BP

Bruce Pritchard

Chief Executive Officer

Liminal BioSciences

Cambridge, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Liminal BioSciences
Industry
research
Employees
22.0
Seniority
C suite
Annual Revenue
154000.0

Technologies

Outlook Microsoft Office 365 Google Tag Manager CrazyEgg WordPress.org Google Analytics Google Maps Linkedin Marketing Solutions Mobile Friendly Twitter Advertising Nginx reCAPTCHA Google Maps (Non Paid Users) AI

Keywords

biotechnology life sciences biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceutical small molecules drug discovery g protein-coupled receptors gpcr metabolic diseases fibrotic diseases inflammatory diseases antagonist agonist clinical development therapeutics selective antagonists novel therapeutics biologics medicinal chemistry pharmaceutical research preclinical trials phase 1 trials phase 2 trials phase 3 trials nash nafld ibd ipf eosinophilic asthma type 2 diabetes clinical trials unmet medical needs drug candidates potent therapeutics therapeutic development candidate selection lead optimization molecular switches signaling pathways patient access chronic diseases endocrine system pulmonary system safety profiles lower dosing cost-effective drug mechanisms molecular biology competitive therapeutic resource allocation team collaboration scientific research health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans